6 research outputs found

    New approaches in component design for dye-sensitized solar cells

    No full text
    Abstract The present perspective presents a number of issues related to the current direction of DSSC research, with emphasis on the transition from iodide-containing electrolyte to charge-transport media (CTMs), electrolytes or solid-state conductors based on inorganic coordination complexes, aiming to attain a better light-to-electricity conversion efficiency, associated with larger photovoltage, and long-term stability. Such a change necessitates the concomitant introduction of novel dyes and counter electrodes. The first part of the perspective introduces an overview of the DSSC field and a number of considerations related to the transition from the triiodide/iodide-based CTM to CTMs based on alternative systems. Subsequently, the recent developments of CTM based on Cu coordination complexes are discussed, from the inorganic physical chemistry point of view, including some highlights about novel dyes associated to these CTMs. Finally, several preparation methods and applications of different types of novel carbonaceous counter electrode substrates, related to the application of the aforementioned novel CTMs, are presented

    Omicron’s binding to sotrovimab, casirivimab, imdevimab, CR3022, and sera from previously infected or vaccinated individuals

    Get PDF
    SARS-CoV-2 Omicron is the first pandemic variant of concern exhibiting an abrupt accumulation of mutations particularly in the receptor-binding domain that is a critical target of vaccination induced and therapeutic antibodies. Omicron's mutations did only marginally affect the binding of ACE2, and the two antibodies Sotrovimab and CR3022 but strongly impaired the binding of Casirivimab and Imdevimab. Moreover, as compared with Wuhan, there is reduced serum reactivity and a pronounced loss of competitive surrogate virus neutralization (sVN) against Omicron in naïve vaccinees and in COVID-19 convalescents after infection and subsequent vaccination. Finally, although the booster vaccination response conferred higher titers and better sVN, the effect was nonetheless significantly lower compared with responses against Wuhan. Overall, our data suggest that the antigenicity of Omicrons receptor binding motive has largely changed but antibodies such as Sotrovimab targeting other conserved sites maintain binding and therefore hold potential in prophylaxis and treatment of Omicron-induced COVID-19
    corecore